A low-glycemic sweetener for metabolic management
Innosweet®, a low-glycemic sweetener with D-Pinitol, is gaining attention as weight and metabolic management move beyond calorie-counting. Consumers and formulators are increasingly focused on the metabolic impact of sweeteners, seeking options that deliver sweetness with a reduced glycemic and insulin response.
This Consumer Trends & Insights Report explores how weight and metabolic management are being redefined around metabolic balance and reduced sugar impact, and why the choice of sweetener is becoming central to this category. It provides strategic insights into how Innosweet® fits formulations designed for healthy metabolic balance.
Unlike crude carob syrups, Innosweet® is a clean-label, non-GMO, composition-controlled matrix of balanced sugars and D-Pinitol, produced through a water-only process with no solvents. In human clinical research, Innosweet® was associated with a lower insulin response while maintaining stable blood glucose levels, providing brands with a standardized, science-backed sweetener for metabolic-wellness products.
These statements have not been evaluated by the Food and Drug Administration. Innosweet® is an ingredient and is not intended to diagnose, treat, cure, or prevent any disease.